Investors Relation

Your gateway to financial insights and company updates.

Who we are

Corporate Profile

Tikva Allocell is a pre-clinical stage biotechnology company focused on Highly Differentiated, Enhanced, Allogeneic EBV Specific T cell platform, targeting difficult to treat, unmet medical patient population. Founded and led by a team with significant experience in cell therapy, we are developing a pipeline of “off-the-shelf” CAR T cell candidates with the goal of delivering readily available cell therapy, more reliably, and at greater scale to more patients.

Tikva Allocell is excited to work with investors as we continue to raise additional funding to unlock the potential of our IP protected ALLO EBVST platform.

Press Releases
Featured Press Release

Tikva Allocell joins the Johnson & Johnson Innovation – JLABS community

Tikva Allocell joins the Johnson & Johnson Innovation – JLABS community
Read More →
Featured Press Release

Tikva Allocell Announces Exclusive Licensing of Cell Therapy Technologies from Baylor College of Medicine

Tikva announces exclusive licensing of novel cell therapy technologies from Baylor College of Medicine to progress its pipeline of promising cell therapies against solid tumors.
Read More →
Featured Press Release

Tikva Allocell announces Joint Laboratory with A*STAR’s Institute of Molecular and Cell Biology

Tikva announces setting up of joint laboratory with A*STAR’s Institute of Molecular and Cell Biology (IMCB) to progress its pipeline of promising cell
Read More →
Events

Tikva is attending the 2nd Singapore Innovation & Enterprise Startup Showcase

We are pleased to announce our upcoming presentation at the 2nd Singapore Innovation and Enterprise Showcase happening alongside the JP Morgan Healthcare Conference in SF.
Read More →
Events

Tikva is attending JPM week 2024

We are invited to the highly anticipated JP Morgan Healthcare Conference in January 8-11, 2024 at San Fransisco, California. We hope to meet you there!
Read More →
Featured Press Release

We are Tikva Allocell

Tikva Allocell founded on 1st of July 2023.
Read More →

Investor Contact